• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Identifying Potential Adverse Drug Events in Tweets Using
Identifying Potential Adverse Drug Events in Tweets Using

... more loosely define any overlapping period of drug treatment and adverse medical effects. Importantly, ADEs do not imply causation between the drug use and co-occurring negative event (Eriksson et al., 2013). Timely, accurate identification of these medical complications therefore facilitates improv ...
Revised: May 2017 AN: 00069/2017 SUMMARY OF PRODUCT
Revised: May 2017 AN: 00069/2017 SUMMARY OF PRODUCT

... Echinococcus multilocularis is a tapeworm of foxes, dogs and cats which is common in parts of Europe. It can also infect humans potentially causing severe liver disease which can be fatal. To prevent Echinococcus multilocularis establishing in the UK and Ireland it is a requirement that all dogs mus ...
New Antiepileptic Drugs
New Antiepileptic Drugs

Antidepressant drug interactions: evidence and clinical significance
Antidepressant drug interactions: evidence and clinical significance

... May increase the plasma levels of TCAs Bupropion (can double the plasma levels of desipramine) ...
Acetic anhydride Product Number A6404 Store at - Sigma
Acetic anhydride Product Number A6404 Store at - Sigma

... 10. Belosludtsev, Y., et al., DNA microarrays based on noncovalent oligonucleotide attachment and hybridization in two dimensions. Anal. Biochem., ...
Vioxx Report.indd - The Physicians Committee
Vioxx Report.indd - The Physicians Committee

... The Need for Revision of Pre-Market Testing: The Failure of Animal Tests of COX-2 Inhibitors Summary Statement patients have been exposed over long periods, it is very possible to evaluate candidate drugs more accurately by replacing animal studies with superior evaluation methods. These methods in ...
Chirally Pure NoN-Steroidal aNti
Chirally Pure NoN-Steroidal aNti

... human body. The two mirror images of a chiral molecule are termed R and S enantiomers. Both enantiomers have the same chemical composition and structure, but in chiral environments such as the receptors and enzymes in the body, they can behave differently. A racemate or a racemic mixture is a mixtur ...
Avances en el desarrollo de productos biológicos para
Avances en el desarrollo de productos biológicos para

the role of the medicinal chemist in drug discovery — then and now
the role of the medicinal chemist in drug discovery — then and now

... basis of these hypotheses, specific objectives will be set for the project. Then, testing selected chemicals in appropriate biological tests can begin. Key subsequent steps in the process include detecting relevant biological activity (a ‘hit’) for a structurally novel compound in vitro, then findin ...
OCULAR DRUG DELIVERY: TARGETING THE POSTERIOR
OCULAR DRUG DELIVERY: TARGETING THE POSTERIOR

Summer Newsletter June 2016
Summer Newsletter June 2016

... Gold Coast Health Plan | Pharmacy Newsletter | June 2016 ...
Pharm Profil-PANNARELLA-Apr PV
Pharm Profil-PANNARELLA-Apr PV

bioidentical hormones - CPD University of Toronto
bioidentical hormones - CPD University of Toronto

... Salivary assays are not recommended for clinical use because of variable concentrations Individual cycles show variability from day to day and have limited use ...
kinetics.
kinetics.

... Placental barrier. Placental membranes are lipoidal and allow free passage of lipophilic drug, while restricting hydrophilic drugs. The placental P-gp also serves to limit foetal exposure to maternally administered drugs. However restricted amounts of nonlipid soluble drugs, when present in high co ...
the benefits of incremental innovation
the benefits of incremental innovation

... what critics mean when they refer to a “me-too” drug. While the term has been applied loosely to any new drug added to an already existing class, it generally refers to drugs that have a similar molecular structure, which are used to treat the same conditions (although we will show that his is not a ...
Merck & Co. Seminar Prep
Merck & Co. Seminar Prep

... worldwide withdrawal of Vioxx® (rofecoxib) from the market due to an increased risk of serious thrombotic cardiovascular adverse events is associated with all COX 2 selective NSAIDs – There are over 16,000 pending lawsuits against Merck, who is litigating them individually • As of 7/14/06, Merck’s r ...
NRDC: FDA`s Efforts Fail to End Misuse of Livestock Antibiotics
NRDC: FDA`s Efforts Fail to End Misuse of Livestock Antibiotics

3.2_Kleinschmidt_SupplementsHerbs (KCK from own)4.23.12
3.2_Kleinschmidt_SupplementsHerbs (KCK from own)4.23.12

... –  Botanicals (plants/herbs), vitamins, amino acids, food additives (or any combination of) –  Supplements diet –  20,000-30,000 on the market •  Herb –  Certain leafy plants without woody stems –  Preparations often include “nonherb” plant materials (and even animal and mineral products) –  “Supple ...
'  STATE OF WISCONSIN DEPARTMENT OF JUSTICE
' STATE OF WISCONSIN DEPARTMENT OF JUSTICE

... characteristics" : (a) "their benefits outweigh their risks," (b) "the potential for misuse and abuse is low," (c) the "consumer can use them for self-diagnosed conditions," (d) "they can be adequately labeled" and (e) "health practitioners are not needed for the safe and effective use of the produc ...
Physicochemical properties of drug action
Physicochemical properties of drug action

... INTRODUCTION TO MEDICINAL CHEMISTRY ...
May 26, 2011 - Eleison Selects CRO Pharm
May 26, 2011 - Eleison Selects CRO Pharm

... including statements regarding Eleison’s product candidates, their uses and potential benefits and clinical trial results and plans. These statements involve risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. Potential risks and ...
AusPAR: Triptorelin acetate
AusPAR: Triptorelin acetate

The Deadly World of Fake Drugs
The Deadly World of Fake Drugs

... nearly every observer and researcher on the hunt for these dangerous fakes will point to two primary culprits: China and India. My own research on antimalarial drugs suggests that 60 to 80 percent of those fake drugs come from these two countries alone. “The overwhelming volume of counterfeit pharma ...
No Slide Title - Delmar Cengage Learning
No Slide Title - Delmar Cengage Learning

... – Weakly acid drugs = hydrophilic form in alkaline environment – Weakly alkaline drugs = hydrophilic form in acid environment ...
The History of Standardized Vaccine Development Current Vaccine
The History of Standardized Vaccine Development Current Vaccine

... Vaccines and Related Biological Products Advisory Committee (VRBPAC), a non-FDA panel of experts that reviews the findings and either supports or opposes licensing of the vaccine to the FDA. The FDA then decides whether or not to grant the license. If the Office of Vaccines Research and Review in CB ...
< 1 ... 78 79 80 81 82 83 84 85 86 ... 193 >

Biosimilar

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is a copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ""innovator"" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.Unlike the more common small-molecule drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers do not have access to the originator's molecular clone and original cell bank, nor to the exact fermentation and purification process, nor to the active drug substance. They do have access to the commercialized innovator product.Drug related authorities such as European Medicines Agency (EMA), Food and Drug Administration (FDA), and Health Canada hold their own guidance on requirements for demonstration of the similar nature of two biological products in terms of safety and efficacy. According to them, analytical studies that demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components; animal studies (including the assessment of toxicity); and a clinical study or studies (including the assessment of immunogenicity and pharmacokinetics or pharmacodynamics) that are sufficient to demonstrate safety, purity, and potency in one or more appropriate conditions of use for which the reference product is licensed and intended to be used and for which licensure is sought for the biological product.In case of a monoclonal antibody-containing medicinal product, such as Remsima, extensive physicochemical and biological characterization for it and its reference product Remicade was conducted in order to demonstrate their highly similar properties. Consequently, EMA have granted a marketing authorisation for only a few numbers of biosimilars since 2006 including a monoclonal antibody which is recently approved. Meanwhile, on March 6, 2015, the FDA approved the United States's first biosimilar product, the biosimilar filgrastim Zarxio.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report